Skip to content

Lextemy – patient leaflet, side effects, dosage

Contains active substance:: Bevacizumab
ATC code:: L01XC07 bevacizumab
Similar medicines:: Equidacent

Zirabev

Onbevzi

Alymsys

Mvasi

Oyavas

Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron)

Riximyo

Kanjinti

Blincyto

Rituzena (previously Tuxella)

MabThera

Patient leaflet - Lextemy

Sources: Original PDF (ema.europa.eu)

The drug is classified in the ATC tree:

L Antineoplastic and immunomodulating agents

L01 Antineoplastic agents

L01X Other antineoplastic agents

L01XC Monoclonal antibodies, antineoplastic

L01XC07 bevacizumab